NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced today that it has priced its previously announced underwritten public offering. The company is selling 8,771,930 shares of common stock at $171 per share for expected gross proceeds of approximately $1.5 billion before the underwriting discount and expenses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.